Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.

Roussel M, Lauwers-Cances V, Macro M, Leleu X, Royer B, Hulin C, Karlin L, Perrot A, Touzeau C, Chrétien ML, Rigaudeau S, Dib M, Nicolas-Virelizier E, Escoffre-Barbe M, Belhadj K, Mariette C, Stoppa AM, Araujo C, Doyen C, Fontan J, Kolb B, Garderet L, Brechignac S, Malfuson JV, Jaccard A, Lenain P, Borel C, Hebraud B, Benbrahim O, Dorvaux V, Manier S, Augeul-Meunier K, Vekemans MC, Randriamalala E, Chaoui D, Caers J, Chaleteix C, Benboubker L, Vincent L, Glaisner S, Zunic P, Slama B, Eveillard JR, Humbrecht-Kraut C, Morel V, Mineur P, Eisenmann JC, Demarquette H, Richez V, Vignon M, Caillot D, Facon T, Moreau P, Colin AL, Olivier P, Wuilleme S, Avet-Loiseau H, Corre J, Attal M

Open source

DOI
10.1182/blood.2021014635
Published
2022 May 5
Container
Blood
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2021014635,
  title = {Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.},
  author = {Roussel M and Lauwers-Cances V and Macro M and Leleu X and Royer B and Hulin C and Karlin L and Perrot A and Touzeau C and Chrétien ML and Rigaudeau S and Dib M and Nicolas-Virelizier E and Escoffre-Barbe M and Belhadj K and Mariette C and Stoppa AM and Araujo C and Doyen C and Fontan J and Kolb B and Garderet L and Brechignac S and Malfuson JV and Jaccard A and Lenain P and Borel C and Hebraud B and Benbrahim O and Dorvaux V and Manier S and Augeul-Meunier K and Vekemans MC and Randriamalala E and Chaoui D and Caers J and Chaleteix C and Benboubker L and Vincent L and Glaisner S and Zunic P and Slama B and Eveillard JR and Humbrecht-Kraut C and Morel V and Mineur P and Eisenmann JC and Demarquette H and Richez V and Vignon M and Caillot D and Facon T and Moreau P and Colin AL and Olivier P and Wuilleme S and Avet-Loiseau H and Corre J and Attal M},
  year = {2022},
  journal = {Blood},
  doi = {10.1182/blood.2021014635},
  url = {https://doi.org/10.1182/blood.2021014635}
}

RIS

TY  - JOUR
TI  - Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
AU  - Roussel M
AU  - Lauwers-Cances V
AU  - Macro M
AU  - Leleu X
AU  - Royer B
AU  - Hulin C
AU  - Karlin L
AU  - Perrot A
AU  - Touzeau C
AU  - Chrétien ML
AU  - Rigaudeau S
AU  - Dib M
AU  - Nicolas-Virelizier E
AU  - Escoffre-Barbe M
AU  - Belhadj K
AU  - Mariette C
AU  - Stoppa AM
AU  - Araujo C
AU  - Doyen C
AU  - Fontan J
AU  - Kolb B
AU  - Garderet L
AU  - Brechignac S
AU  - Malfuson JV
AU  - Jaccard A
AU  - Lenain P
AU  - Borel C
AU  - Hebraud B
AU  - Benbrahim O
AU  - Dorvaux V
AU  - Manier S
AU  - Augeul-Meunier K
AU  - Vekemans MC
AU  - Randriamalala E
AU  - Chaoui D
AU  - Caers J
AU  - Chaleteix C
AU  - Benboubker L
AU  - Vincent L
AU  - Glaisner S
AU  - Zunic P
AU  - Slama B
AU  - Eveillard JR
AU  - Humbrecht-Kraut C
AU  - Morel V
AU  - Mineur P
AU  - Eisenmann JC
AU  - Demarquette H
AU  - Richez V
AU  - Vignon M
AU  - Caillot D
AU  - Facon T
AU  - Moreau P
AU  - Colin AL
AU  - Olivier P
AU  - Wuilleme S
AU  - Avet-Loiseau H
AU  - Corre J
AU  - Attal M
PY  - 2022
JO  - Blood
DO  - 10.1182/blood.2021014635
UR  - https://doi.org/10.1182/blood.2021014635
ER  -

APA

M, R., V, L., M, M., X, L., B, R., C, H., L, K., A, P., C, T., ML, C., S, R., M, D., E, N., M, E., K, B., C, M., AM, S., C, A., C, D., J, F., B, K., L, G., S, B., JV, M., A, J., P, L., C, B., B, H., O, B., V, D., S, M., K, A., MC, V., E, R., D, C., J, C., C, C., L, B., L, V., S, G., P, Z., B, S., JR, E., C, H., V, M., P, M., JC, E., H, D., V, R., M, V., D, C., T, F., P, M., AL, C., P, O., S, W., H, A., J, C., & M, A. (2022). Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.. Blood. https://doi.org/10.1182/blood.2021014635

Source records